Clinical Trial Update: An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) [Phase 2]

View source ↗

Summary

A phase 2 exploratory trial studying the combination of atezolizumab and bevacizumab in hepatocellular carcinoma and metastatic non-small cell lung cancer with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma, Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING